Adage Capital Partners’s Protagonist Therapeutics PTGX Stock Holding History

Adage Capital Partners’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$60.4M	Buy	1,092,262 +748,758	+218%	+$41.4M	0.1%	193
2025 Q1	$16.6M	Buy	+343,504	New	+$16.6M	0.03%	464
2024 Q4	–	Sell	-1,200,891	Closed	-$54M	–	944
2024 Q3	$54M	Sell	1,200,891 -800,451	-40%	-$36M	0.1%	218
2024 Q2	$69.3M	Sell	2,001,342 -217,526	-10%	-$7.54M	0.13%	167
2024 Q1	$64.2M	Buy	2,218,868 +927,167	+72%	+$26.8M	0.12%	184
2023 Q4	$29.6M	Buy	1,291,701 +591,701	+85%	+$13.6M	0.06%	322
2023 Q3	$11.7M	Sell	700,000 -592,711	-46%	-$9.89M	0.03%	531
2023 Q2	$35.7M	Sell	1,292,711 -1,265,289	-49%	-$34.9M	0.08%	261
2023 Q1	$58.8M	Buy	2,558,000 +1,790,955	+233%	+$41.2M	0.13%	180
2022 Q4	$8.37M	Sell	767,045 -106,000	-12%	-$1.16M	0.02%	673
2022 Q3	$7.36M	Sell	873,045 -127,000	-13%	-$1.07M	0.02%	717
2022 Q2	$7.91M	Buy	1,000,045 +400,000	+67%	+$3.16M	0.02%	729
2022 Q1	$14.2M	Buy	600,045 +150,000	+33%	+$3.55M	0.03%	597
2021 Q4	$15.4M	Buy	450,045 +150,000	+50%	+$5.13M	0.03%	572
2021 Q3	$5.32M	Sell	300,045 -250,000	-45%	-$4.43M	0.01%	825
2021 Q2	$24.7M	Sell	550,045 -50,000	-8%	-$2.24M	0.05%	386
2021 Q1	$15.5M	Sell	600,045 -550,000	-48%	-$14.2M	0.03%	542
2020 Q4	$23.2M	Sell	1,150,045 -1,370,555	-54%	-$27.6M	0.05%	383
2020 Q3	$49.3M	Buy	2,520,600 +320,600	+15%	+$6.27M	0.12%	181
2020 Q2	$38.9M	Buy	+2,200,000	New	+$38.9M	0.1%	231
2018 Q3	–	Sell	-500,000	Closed	-$3.36M	–	749
2018 Q2	$3.36M	Sell	500,000 -500,000	-50%	-$3.36M	0.01%	675
2018 Q1	$8.59M	Sell	1,000,000 -1,056,076	-51%	-$9.07M	0.02%	583
2017 Q4	$42.8M	Hold	2,056,076	–	–	0.1%	253
2017 Q3	$36.3M	Hold	2,056,076	–	–	0.09%	282
2017 Q2	$23.3M	Buy	2,056,076 +400,000	+24%	+$4.52M	0.06%	383
2017 Q1	$21.2M	Buy	1,656,076 +125,000	+8%	+$1.6M	0.05%	388
2016 Q4	$33.7M	Sell	1,531,076 -50,000	-3%	-$1.1M	0.09%	273
2016 Q3	$33.4M	Buy	+1,581,076	New	+$33.4M	0.09%	291